COVID-19
Nasal swab eluates for COVID-19
Year Started: 2019
Clinical discard specimens in a variety of transport media. Tested positive or negative by USFDA EUA COVID-19 molecular test. Subset of specimens available with Ct values for positives. Up to 250µL available per specimen. Negative pools available for some transport media.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Human genetic analysis restriction, Scope of use restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | Immediate |
| Freezer temperature logs | Immediate |
| Genomic datasets | Immediate |
| Pre-analytical data | Immediate |
| Physiological/biochemical measurements | Immediate |
Undifferentiated
Data not recorded
3001 - 5000 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Swab medium | -85°C to -60°C | Not applicable |
COVID-19
Longitudinal serum and plasma
Year Started: 2019
Serum and plasma collected at 1, 2, 4, 8, and 14 weeks post COVID-19 clinical diagnosis
- Access:
- Open to applicants
- Type:
- Longitudinal
- Status:
- Completed
- Consent restrictions:
- Human genetic analysis restriction, Scope of use restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | Immediate |
| Clinical records | 0 - 3 months |
| Followup records | 0 - 3 months |
| Freezer temperature logs | Immediate |
| Quality indicators | Immediate |
| Participant Ethnicity | 0 - 3 months |
Both sexes
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma (single spun) | -85°C to -60°C | Not applicable | |||
| Serum | -85°C to -60°C | Not applicable |